Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

IDEC receives patent coverage for platform technology

Feb. 12, 1997

Merck & Co. and Costa Rican institute renew biological diversity agreement

Feb. 11, 1997

Genentech funds basic research related to human birth defects

Feb. 10, 1997

Vyrex gene discovery platform receives patent coverage

Feb. 10, 1997

Zynaxis sells drug delivery technology

Feb. 7, 1997

Abgenix reports significant advance in human antibody technology

Feb. 6, 1997

LifeTECH and Pall announce collaboration

Feb. 6, 1997

ICOS/Glaxo Wellcome collaboration modified

Feb. 4, 1997

Cytogen/Elan oral drug delivery collaboration advances

Feb. 4, 1997

Zeneca/Pharmacopeia collaboration signed

Jan. 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...